Mangalam Drugs

3
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
24.01
-0.29 (-1.19%)
BSENSE

Dec 19

BSE+NSE Vol: 90.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
No of Months
12
12
Operating Income
318.00
368.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
318.00
368.00
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
9.00
Raw Materials Consumed
188.00
235.00
Power & Fuel Cost
27.00
28.00
Employee Cost
40.00
39.00
Operating Expenses
17.00
12.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
8.00
6.00
Cost of Software developments
0.00
0.00
Miscellaneous Expenses
14.00
12.00
Expenses Capitalised
0.00
0.00
Total Expenditure
282.00
351.00
Operating Profit (PBDIT) excl Other Income
35.00
17.00
Other Income
0.00
0.00
Operating Profit (PBDIT)
36.00
17.00
Interest
14.00
13.00
Profit before Depriciation and Tax
21.00
3.00
Depreciation
16.00
14.00
Profit Before Taxation & Exceptional Items
4.00
-11.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
4.00
-11.00
Provision for Tax
-1.00
-2.00
Profit After Tax
6.00
-9.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
86.00
102.00
Profit Available for appropriations
93.00
93.00
Appropriations
93.00
93.00
Equity Dividend (%)
0.00%
0.00%
Earnings Per Share
4.25
-5.73
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -13.66% vs NA in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 106.13% vs NA in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 7.30% vs NA in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 174.09% vs NA in Mar 2024

Compare Profit and Loss Results of Mangalam Drugs
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
318.00
25.00
293.00
1,172.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
318.00
25.00
293.00
1,172.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
0.00
-21.00
0%
Raw Materials Consumed
188.00
10.00
178.00
1,780.00%
Power & Fuel Cost
27.00
1.00
26.00
2,600.00%
Employee Cost
40.00
7.00
33.00
471.43%
Operating Expenses
17.00
0.00
17.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
8.00
1.00
7.00
700.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
0.00
14.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
282.00
27.00
255.00
944.44%
Operating Profit (PBDIT) excl Other Income
35.00
-1.00
36.00
3,600.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
36.00
0.00
36.00
0%
Interest
14.00
0.00
14.00
0%
Profit before Depriciation and Tax
21.00
0.00
21.00
0%
Depreciation
16.00
1.00
15.00
1,500.00%
Profit Before Taxation & Exceptional Items
4.00
0.00
4.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
0.00
4.00
0%
Provision for Tax
-1.00
0.00
-1.00
0%
Profit After Tax
6.00
0.00
6.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
86.00
61.00
25.00
40.98%
Profit Available for appropriations
93.00
61.00
32.00
52.46%
Appropriations
93.00
61.00
32.00
52.46%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.25
-0.46
4.71
1,023.91%
Profit And Loss - Net Sales
Net Sales 318.23 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -13.66% vs NA in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.82 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 106.13% vs NA in Mar 2024

Profit And Loss - Interest
Interest 14.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.30% vs NA in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 6.72 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 174.09% vs NA in Mar 2024